Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theratechnologies Inc.

2.52
-0.0500-1.95%
Post-market: 2.550.0300+1.19%19:59 EDT
Volume:771.92K
Turnover:1.99M
Market Cap:115.87M
PE:-33.55
High:2.67
Open:2.60
Low:2.51
Close:2.57
Loading ...

Theratechnologies Inc expected to post earnings of 3 cents a share - Earnings Preview

Reuters
·
07 Apr

Theratechnologies Inc expected to post earnings of 3 cents a share - Earnings Preview

Reuters
·
04 Apr

Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update

GlobeNewswire
·
04 Apr

US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

Benzinga
·
26 Mar

Theratechnologies Shares Soar Premarket on FDA Approval of New Formulation of Excess Abdominal Fat Treatment

MT Newswires Live
·
26 Mar

Theratechnologies Shares Rise on FDA Approval for HIV-Induced Stomach Fat Treatment

Dow Jones
·
26 Mar

Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy

GlobeNewswire
·
26 Mar

JonesTrading Reaffirms Their Hold Rating on Theratechnologies (THTX)

TIPRANKS
·
06 Mar

Theratechnologies Inc (THTX) Q4 2024 Earnings Call Highlights: Strong EBITDA Turnaround and ...

GuruFocus.com
·
27 Feb

Theratechnologies Inc reports results for the quarter ended November 30 - Earnings Summary

Reuters
·
26 Feb

Theratechnologies: Fiscal Q4 Earnings Snapshot

Associated Press Finance
·
26 Feb

Theratechnologies Q4 2024 GAAP EPS $(0.16) May Not Be Comparable To $0.05 Estimate, Sales $25.00M Beat $22.69M Estimate

Benzinga
·
26 Feb

Theratechnologies Inc expected to post earnings of 5 cents a share - Earnings Preview

Reuters
·
24 Feb

Theratechnologies upgraded to Buy from Speculative Buy at Mackie Research

TIPRANKS
·
14 Feb

Theratechnologies to resume distribution of EGRIFTA

TIPRANKS
·
14 Feb

Theratechnologies Resumes Distribution of EGRIFTA SV®

GlobeNewswire
·
14 Feb

Theratechnologies expects Egrifta SV shortage this month

TIPRANKS
·
10 Jan

Theratechnologies Warns of Upcoming Shortage for HIV-Induced Stomach Fat Treatment

Dow Jones
·
10 Jan

Theratechnologies Submits FDA Prior Approval Supplement for Egrifta Manufacturing Changes

MT Newswires Live
·
19 Dec 2024

Theratechnologies announces filing of PAS with FDA for manufacturing environment

TIPRANKS
·
19 Dec 2024